Загрузка...
Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?
The prognosis of patients with metastatic melanoma has substantially improved over the last years with the advent of novel treatment strategies, mainly immune checkpoint inhibitors and BRAF and MEK inhibitors. Given the survival benefit provided in the metastatic setting and the evidence from prospe...
Сохранить в:
| Опубликовано в: : | Am J Clin Dermatol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8200339/ https://ncbi.nlm.nih.gov/pubmed/34036489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-021-00608-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|